Catchet-MS identifies IKZF1-targeting Thalidomide analogues as novel HIV-1 latency reversal agents
Enrico Ne, Raquel Crespo, Ray W. Izquierdo-Lara, Shringar Rao, Selin Koçer, Alicja Górska, Thomas van Staveren, Tsung Wai Kan, David A. M. C. van de Vijver, Dick H. W. Dekkers, Casper Rokx, Panagiotis Moulos, Pantelis Hatzis, Robert-Jan T. S. Palstra, Jeroen Demmers, Tokameh Mahmoudi
Catchet-MS identifies thalidomide analogues targeting IKZF1 as novel HIV-1 latency reversal agents by reversing latency in CD4+ T-cells.
Nucleic Acids Research · May 30, 2022Peer-reviewedMolecular Biology